FAGR Fagron SA

Disclosure of notification received from BNP Paribas Asset Management SA

Disclosure of notification received from BNP Paribas Asset Management SA

Regulated information

Nazareth (Belgium)/Rotterdam (The Netherlands), 9 November 2023 – 6PM CET

Disclosure of notification received from BNP Paribas Asset Management SA

Fagron received a notification pursuant to the Belgian law of 2 May 2007 regarding the disclosure of major shareholdings in listed companies from BNP Paribas Asset Management SA.

Notification of BNP Paribas Asset Management SA

  • On 8 November 2023, Fagron received a notification that the shareholding of BNP Paribas Asset Management SA crossed the disclosure threshold of 3% on 31 October 2023 as the result of the acquisition of voting securities or voting rights.
  • The notification is made by a ‘parent undertaking or a controlling person’.
  • On 31 October 2023, BNP Paribas Asset Management SA held a total of 2,215,303 voting rights. 1,999,787 voting rights are held by BNP Paribas Asset Management France SAS, and 215,516 voting rights are held by BNP Paribas Asset Management UK Limited.
  • Based on the denominator of 73,228,904 (total number of voting rights), BNP Paribas Asset Management SA held 3.03% of the total number of voting rights on 31 October 2023.
  • The full chain of controlled undertakings through which the holding is effectively held is as follows: since 1 January 2023, BNP Paribas Asset Management Belgium NV has been renamed BNP Paribas Asset Management France, Belgian Branch, a branch of BNP Paribas Asset Management France SAS. The subsidiary BNP Paribas Asset Management France SAS and the subsidiary BNP Paribas Asset Management UK Ltd are controlled by the parent company BNP Paribas Asset Management SA. This parent company is controlled by the parent company BNP Paribas SA, which is exempt from aggregating its holdings with those of its subsidiary investment companies, in accordance with article 21 paragraph 2 of the Royal Decree of 14 February 2008 on the disclosure of major holdings.
  • BNP Paribas Asset Management France SAS and BNP Paribas Asset Management UK Ltd are investment companies that exercise voting rights on a discretionary basis.
  • BNP Paribas Asset Management SA’s notification can be viewed via this .



Further information

Karen Berg

Global Investor Relations Manager

Tel. 99

About Fagron

Fagron is a leading global company active in pharmaceutical compounding, focusing on delivering personalized medicine to hospitals, pharmacies, clinics and patients in more than 30 countries around the world.

Belgian company Fagron NV has its registered office in Nazareth and is listed on Euronext Brussels and Euronext Amsterdam under the ticker symbol ‘FAGR’. Fagron’s operational activities are managed by the Dutch company Fagron BV, which is headquartered in Rotterdam.

In the event of differences between the English translation and the Dutch original of this press release, the latter prevails.

Attachment



EN
09/11/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Fagron SA

 PRESS RELEASE

Fagron completes strategic acquisition of Pharmavit Europe, strengthen...

Fagron completes strategic acquisition of Pharmavit Europe, strengthening its leadership in high‑growth nutraceutical ingredients across EMEA Regulated information – inside information Nazareth (Belgium)/Rotterdam (The Netherlands), 26 February 2026 – 6:30PM Fagron completes strategic acquisition of Pharmavit Europe, strengthening its leadership in high‑growth nutraceutical ingredients across EMEA Fagron, the leading global player in pharmaceutical compounding, announces that it has completed the acquisition of Pharmavit Europe, a leading European distributor of nutraceutical raw material...

 PRESS RELEASE

Fagron voltooit strategische overname van Pharmavit Europe en versterk...

Fagron voltooit strategische overname van Pharmavit Europe en versterkt daarmee haar leiderschap in snelgroeiende nutraceutische ingrediënten in EMEA Gereglementeerde informatie - voorwetenschapNazareth (België)/Rotterdam (Nederland), 26 februari 2026 – 18:30 Fagron voltooit strategische overname van Pharmavit Europe en versterkt daarmee haar leiderschap in snelgroeiende nutraceutische ingrediënten in EMEA Fagron, de toonaangevende wereldwijde speler in farmaceutische bereidingen, kondigt de afronding aan van de overname van Pharmavit Europe, een toonaangevende Europese distributeur van ...

Robert Jan Vos ... (+2)
  • Robert Jan Vos
  • Usama Tariq

ResearchPool Subscriptions

Get the most out of your insights

Get in touch